Terazosin

Product NDC
72162-1702
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Terazosin Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA075317
Marketing category
ANDA
Substance
TERAZOSIN HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
72162-1702-01000 CAPSULE in 1 BOTTLE (72162-1702-0) 2023-12-07NoHistorical
72162-1702-1100 CAPSULE in 1 BOTTLE (72162-1702-1) 2023-12-07NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
TERAZOSIN CAPSULES, USPBryant Ranch Prepack2025-11-03HUMAN PRESCRIPTION DRUG LABEL103
TERAZOSIN CAPSULES, USPBryant Ranch Prepack2024-02-07HUMAN PRESCRIPTION DRUG LABEL102